论文部分内容阅读
目的:探讨依托咪酯联合异丙酚在无痛人流术中应用的临床价值。方法:整理分析我院2013年3月-2014年2月242例行无痛人流术的患者资料,将患者随机平均分为两组,分别实施芬太尼联合依托咪酯和依托咪酯联合异丙酚进行静脉麻醉,对两组患者的麻醉效果,停药唤醒时间和不良反应的情况进行统计分析,比较两组临床效果的差异。结果:实验组患者和对照组患者在停药后唤醒时间上差异不显著(P>0.05),实验组麻醉效果和不良反应的发生率上明显优于对照组(P<0.05)。结论:选用依托咪酯联合异丙酚对无痛人流术进行静脉麻醉,临床效果确切,不良反应少,是一种安全有效的麻醉方案,可在临床上广泛应用。
Objective: To investigate the clinical value of etomidate combined with propofol in painless abortion. Methods: The data of 242 cases of painless abortion in our hospital from March 2013 to February 2014 were analyzed and divided into two groups randomly. Patients were treated with combination of etomidate and etomidate Propofol for intravenous anesthesia, the two groups of patients anesthesia, withdrawal time and adverse reactions were statistically analyzed, the difference between the two groups were compared. Results: There was no significant difference in the awakening time between experimental group and control group (P> 0.05). The incidence of anesthesia and adverse reactions in the experimental group was significantly better than that of the control group (P <0.05). Conclusion: The combination of etomidate and propofol for intravenous anesthesia in patients with painless abortion has definite clinical effect and few adverse reactions. It is a safe and effective anesthetic solution and can be widely used clinically.